Theriva Biologics, Inc. Profile Avatar - Palmy Investing

Theriva Biologics, Inc.

Theriva Biologics Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in …

Biotechnology
US, Rockville [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of TOVX's Analysis
CIK: 894158 CUSIP: - ISIN: US87164U4094 LEI: - UEI: -
Secondary Listings
TOVX has no secondary listings inside our databases.